Cite
HARVARD Citation
ABBAS, A. et al. (n.d.). P01.01 A Phase 1a/1b dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer. pp. A7-A8. [Online].